GRA
CHX

Goehring & Rozencwajg Associates’s ChampionX CHX Stock Holding History

Goehring & Rozencwajg Associates’s Portfolio CHX Stock Details CHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-275,041
Closed -$9.85M – 50
2024
Q1 		$9.85M Buy
275,041
+12,974
+5% +$388K 2.13% 16
2023
Q4 		$7.65M Buy
262,067
+9,800
+4% +$303K 1.85% 21
2023
Q3 		$8.99M Buy
252,267
+8,060
+3% +$286K 2.2% 14
2023
Q2 		$7.56M Buy
244,207
+24,290
+11% +$669K 2.17% 14
2023
Q1 		$5.97M Buy
219,917
+8,602
+4% +$257K 2.04% 19
2022
Q4 		$6.1M Buy
+211,315
New +$5.83M 2.17% 17

Other funds holding CHX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goehring & Rozencwajg Associates's CHX Position: Q2 2024 in Review

Goehring & Rozencwajg Associates sold out of ChampionX (CHX) in Q2 2024, closing a stake of 275,041 shares — an estimated $9.85M sold.

Goehring & Rozencwajg Associates first reported a position in CHX in Q4 2022 and held it in 6 quarters. The position peaked at $9.85M in Q1 2024. 432 funds tracked by Wall St. Rank hold CHX as of Q2 2024.

  • Goehring & Rozencwajg Associates reported no remaining ChampionX position as of Q2 2024 after selling out during the quarter.
  • Goehring & Rozencwajg Associates sold 275,041 ChampionX shares in Q2 2024, an estimated $9.85M.
  • Goehring & Rozencwajg Associates first reported a position in ChampionX in Q4 2022 and held it in 6 quarters.
  • Goehring & Rozencwajg Associates's ChampionX position peaked at $9.85M in Q1 2024.
  • 432 funds tracked by Wall St. Rank held ChampionX as of Q2 2024.

Based on Goehring & Rozencwajg Associates's 13F filing for Q2 2024, filed 12 Aug 2024.